Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Inhaled corticosteroids downregulate SARS-CoV-2-related gene expression in COPD: results from a RCT

View ORCID ProfileStephen Milne, Xuan Li, Chen Xi Yang, Ana I Hernandez Cordero, Fernando Sergio Leitao Filho, Cheng Wei Tony Yang, Tawimas Shaipanich, Stephan F van Eeden, Janice M Leung, Stephen Lam, Don D Sin
doi: https://doi.org/10.1101/2020.08.19.20178368
Stephen Milne
1University of British Columbia Centre for Heart Lung Innovation, St Paul’s Hospital, Vancouver, British Columbia, Canada
2University of British Columbia Division of Respiratory Medicine, Vancouver, British Columbia, Canada
3University of Sydney Faculty of Medicine and Health Sciences, Sydney, New South Wales, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stephen Milne
  • For correspondence: Stephen.milne@hli.ubc.ca
Xuan Li
1University of British Columbia Centre for Heart Lung Innovation, St Paul’s Hospital, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chen Xi Yang
1University of British Columbia Centre for Heart Lung Innovation, St Paul’s Hospital, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana I Hernandez Cordero
1University of British Columbia Centre for Heart Lung Innovation, St Paul’s Hospital, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fernando Sergio Leitao Filho
1University of British Columbia Centre for Heart Lung Innovation, St Paul’s Hospital, Vancouver, British Columbia, Canada
2University of British Columbia Division of Respiratory Medicine, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cheng Wei Tony Yang
1University of British Columbia Centre for Heart Lung Innovation, St Paul’s Hospital, Vancouver, British Columbia, Canada
4Providence Health Care Providence Airway Centre, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tawimas Shaipanich
2University of British Columbia Division of Respiratory Medicine, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephan F van Eeden
1University of British Columbia Centre for Heart Lung Innovation, St Paul’s Hospital, Vancouver, British Columbia, Canada
2University of British Columbia Division of Respiratory Medicine, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Janice M Leung
1University of British Columbia Centre for Heart Lung Innovation, St Paul’s Hospital, Vancouver, British Columbia, Canada
2University of British Columbia Division of Respiratory Medicine, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Lam
2University of British Columbia Division of Respiratory Medicine, Vancouver, British Columbia, Canada
5BC Cancer Research Centre Department of Integrative Oncology, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Don D Sin
1University of British Columbia Centre for Heart Lung Innovation, St Paul’s Hospital, Vancouver, British Columbia, Canada
2University of British Columbia Division of Respiratory Medicine, Vancouver, British Columbia, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Rationale Chronic obstructive pulmonary disease (COPD) is a risk factor for severe COVID-19. Inhaled corticosteroids (ICS) are commonly prescribed for the prevention of acute exacerbations in people with COPD, but their use is associated with increased risk of respiratory infections. The effects of ICS on SARS-CoV-2 susceptibility or COVID-19 severity are currently unknown.

Objectives To determine the effects of ICS treatment on the bronchial epithelial cell expression of key SARS-CoV-2-related genes in volunteers with COPD.

Methods We performed a randomized, open-label, parallel treatment trial of 12 weeks treatment with ICS in combination with long-acting beta-agonist (formoterol/budesonide 12/400 µg twice daily or salmeterol/fluticasone propionate 25/250 µg twice daily), or treatment with LABA only (formoterol 12 µg twice daily), in volunteers with mild to very severe COPD. We obtained bronchial epithelial cell samples via bronchoscopy before and after treatment, and determined transcriptome-wide gene expression by RNA sequencing.

Main Results 63 volunteers were randomized to receive treatment. Compared to formoterol alone, formoterol/budesonide treatment decreased the expression of the SARS-CoV-2 receptor gene ACE2 and the host cell protease gene ADAM17. These genes were highly co-expressed with innate immune response genes, particularly those of the type I interferon and anti-viral response pathways, which also tended to decrease following ICS treatment.

Conclusions This is the first randomized controlled trial to show that ICS affect the expression of key SARS-CoV-2-related genes in COPD. Their relation to important anti-viral response genes may have critical implications for SARS-CoV-2 susceptibility or COVID-19 severity in this vulnerable population.

Competing Interest Statement

Dr. Milne reports personal fees from Novartis and Boehringer-Ingelheim, outside the submitted work. Dr. Sin reports grants from AstraZeneca, during the conduct of the study; personal fees from Novartis and Boehringer-Ingelheim, and grants and personal fees from AstraZeneca, outside the submitted work.

Clinical Trial

NCT02833480

Funding Statement

The DISARM study was funded by an investigator-initiated grant from AstraZeneca. Dr. Milne and Dr Hernandez Cordero are supported by the MITACS Accelerate Program.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was approved by the Human Research Ethics Committee of the University of British Columbia and Providence Health Care (H14-02277)

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Requests for data sharing should be made directly to the Principal Investigator, Dr. Don Sin (don.sin@hli.ubc.ca)

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 22, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Inhaled corticosteroids downregulate SARS-CoV-2-related gene expression in COPD: results from a RCT
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Inhaled corticosteroids downregulate SARS-CoV-2-related gene expression in COPD: results from a RCT
Stephen Milne, Xuan Li, Chen Xi Yang, Ana I Hernandez Cordero, Fernando Sergio Leitao Filho, Cheng Wei Tony Yang, Tawimas Shaipanich, Stephan F van Eeden, Janice M Leung, Stephen Lam, Don D Sin
medRxiv 2020.08.19.20178368; doi: https://doi.org/10.1101/2020.08.19.20178368
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Inhaled corticosteroids downregulate SARS-CoV-2-related gene expression in COPD: results from a RCT
Stephen Milne, Xuan Li, Chen Xi Yang, Ana I Hernandez Cordero, Fernando Sergio Leitao Filho, Cheng Wei Tony Yang, Tawimas Shaipanich, Stephan F van Eeden, Janice M Leung, Stephen Lam, Don D Sin
medRxiv 2020.08.19.20178368; doi: https://doi.org/10.1101/2020.08.19.20178368

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Respiratory Medicine
Subject Areas
All Articles
  • Addiction Medicine (269)
  • Allergy and Immunology (551)
  • Anesthesia (135)
  • Cardiovascular Medicine (1751)
  • Dentistry and Oral Medicine (238)
  • Dermatology (172)
  • Emergency Medicine (312)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (655)
  • Epidemiology (10790)
  • Forensic Medicine (8)
  • Gastroenterology (585)
  • Genetic and Genomic Medicine (2938)
  • Geriatric Medicine (286)
  • Health Economics (532)
  • Health Informatics (1921)
  • Health Policy (833)
  • Health Systems and Quality Improvement (744)
  • Hematology (291)
  • HIV/AIDS (628)
  • Infectious Diseases (except HIV/AIDS) (12506)
  • Intensive Care and Critical Care Medicine (686)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (324)
  • Neurology (2788)
  • Nursing (151)
  • Nutrition (432)
  • Obstetrics and Gynecology (556)
  • Occupational and Environmental Health (597)
  • Oncology (1460)
  • Ophthalmology (442)
  • Orthopedics (172)
  • Otolaryngology (255)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (380)
  • Pediatrics (865)
  • Pharmacology and Therapeutics (363)
  • Primary Care Research (334)
  • Psychiatry and Clinical Psychology (2635)
  • Public and Global Health (5349)
  • Radiology and Imaging (1006)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (725)
  • Rheumatology (329)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (278)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (149)
  • Urology (125)